PARSHALL B LYNNE 4
4 · CYTOKINETICS INC · Filed Sep 9, 2024
Insider Transaction Report
Form 4
CYTOKINETICS INCCYTK
PARSHALL B LYNNE
Director
Transactions
- Exercise/Conversion
Common Stock
2024-09-09$21.61/sh+5,000$108,050→ 25,600 total - Sale
Common Stock
2024-09-09$54.92/sh−5,000$274,600→ 20,600 total - Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
2024-09-09−5,000→ 0 totalExercise: $21.61Exp: 2030-05-13→ Common Stock (5,000 underlying)
Footnotes (1)
- [F1]Options shall vest and become exercisable in 12 equal monthly installments as from the date of the grant.